BOC Report and accounts 2005 - Alle jaarverslagen
BOC Report and accounts 2005 - Alle jaarverslagen
BOC Report and accounts 2005 - Alle jaarverslagen
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Financial review<br />
55<br />
Net debt/equity<br />
Percentage<br />
80<br />
60<br />
40<br />
20<br />
0 03 04 05<br />
Net debt/capital employed<br />
Percentage<br />
40<br />
30<br />
20<br />
10<br />
0 03 04 05<br />
Corporate transactions <strong>and</strong> restructuring<br />
In South Africa the disposal of Afrox Healthcare Limited to a consortium lead by two major black empowerment<br />
investors was completed on 22 March <strong>2005</strong>.African Oxygen Limited, <strong>BOC</strong>’s subsidiary in South Africa, retains a<br />
significant interest in the hospitals business through a 20 per cent holding in the new company.The gain on disposal<br />
of £84.9 million has been recognised as an exceptional item.African Oxygen Limited has distributed the proceeds<br />
of the disposal to its shareholders through a buy back of shares <strong>and</strong> a special dividend.The amount of the special<br />
dividend payable to minority shareholders was some £54 million, which is included in the total dividends paid to<br />
minorities in subsidiaries within the Group cash flow statement.<br />
The sale of <strong>BOC</strong>’s packaged gas business in the US to Airgas Inc was completed in July 2004. Part of the<br />
consideration was payable subject to certain conditions <strong>and</strong> accordingly was not recognised in 2004.This remaining<br />
consideration amounting to US$20 million was received in November <strong>2005</strong> <strong>and</strong> has been recognised in <strong>2005</strong> as<br />
an exceptional item.The disposal of the business in 2004 resulted in a loss of £79.5 million plus associated<br />
restructuring costs of £14.8 million.<br />
In <strong>2005</strong> £20.7 million has been charged for restructuring in <strong>BOC</strong> Edwards.This comprises £13.9 million of<br />
goodwill impairment <strong>and</strong> severance costs. Savings of approximately £5 million are targeted from this restructuring<br />
during 2006. Further costs are anticipated from this programme in 2006 leading to additional benefits.<br />
Group expenditure on acquisitions of businesses was £57.1 million (2004: £50.9 million).The main acquisitions<br />
during <strong>2005</strong> were G Van Dongen Holding BV, to exp<strong>and</strong> Gist’s primary business into Europe, <strong>and</strong> an additional<br />
equity investment in Compania de Nitrogeno de Cantarell (CNC) in proportion to <strong>BOC</strong>’s existing 65 per cent<br />
equity holding.The main acquisition in 2004 was to increase <strong>BOC</strong>’s holding in CNC.<br />
Financial indicators<br />
The trends of financial indicators which, taken together, are a measure of the performance <strong>and</strong> efficiency of the<br />
Group’s finance <strong>and</strong> tax structures, are:<br />
<strong>2005</strong> 2004 2003<br />
Interest cover (times) 1 7.1 6.3 4.6<br />
Adjusted interest cover (times) 2 7.4 6.5 5.3<br />
Net debt/equity (%) 40.9 51.2 73.4<br />
Net debt/capital employed (%) 25.6 29.9 37.4<br />
Group tax rate (%) 26.9 24.7 27.4<br />
Adjusted Group tax rate (%) 3 26.0 29.0 29.0<br />
Adjusted means excluding exceptional items.<br />
1. Interest on net debt covered by operating profit.<br />
2. Interest on net debt covered by adjusted operating profit.<br />
3. The adjusted tax charge expressed as a percentage of adjusted profit before tax.<br />
The ratios are commented on below in the appropriate section.<br />
Liquidity <strong>and</strong> capital resources<br />
Cash flows The Group’s cash flows from operating, investing <strong>and</strong> financing activities, as reflected in the Group cash<br />
flow statement on page 88, are summarised in the following table:<br />
<strong>2005</strong> 2004 2003<br />
£ million £ million £ million<br />
Net cash inflow from operating activities 665.5 758.5 700.1<br />
Dividends from joint ventures <strong>and</strong> associates 51.1 79.1 35.0<br />
Returns on investment <strong>and</strong> servicing of finance (131.6) (91.2) (94.4)<br />
Tax paid (118.4) (98.2) (90.7)<br />
Total provided by operating activities 466.6 648.2 550.0<br />
Capital expenditure <strong>and</strong> financial investment (299.7) (204.2) (227.0)<br />
Acquisitions <strong>and</strong> disposals 128.8 92.5 (118.3)<br />
Total used by investing activities (170.9) (111.7) (345.3)<br />
Decreases in debt (165.7) (180.7) (128.7)<br />
Shares issued 9.6 12.4 (2.6)<br />
Equity dividends paid (204.1) (197.3) (192.1)<br />
Net sales/(purchases) of short-term investments 14.3 (20.8) 16.2<br />
Total used for financing activities (345.9) (386.4) (307.2)<br />
(Decrease)/increase in cash (50.2) 150.1 (102.5)